Abstract

Pancreatic cancer represents one of the most aggressive types of malignancy due to its high resistance toward most clinically available treatments. The presence of pancreatic cancer stem-like cells (CSCs) has been attributed to the intrinsically high resistance and highly metastatic potential of this disease. Here, we identified and isolated pancreatic CSCs using the side population (SP) method from human pancreatic cancer cell line, PANC-1. We then compared the SP and non-SP PANC-1 cells genetically. PANC-1 SP cells exhibited CSC properties including enhanced self-renewal ability, increased metastatic potential, and resistance toward gemcitabine treatment. These cancer stem-like phenotypes were supported by their enhanced expression of ABCG2, Oct4, and CD44. A traditional plant-derived antioxidant, garcinol, has been implicated for its anticancer properties. Here, we found that garcinol treatment to PANC-1 SP cells significantly suppressed the stem-like properties of PANC-1 SP cells and metastatic potential by downregulating the expression of Mcl-1, EZH2, ABCG2, Gli-1, and Notch1. More importantly, garcinol treatment led to the upregulation of several tumor suppressor microRNAs, and miR-200c increased by garcinol treatment was found to target and downregulate Notch1. Thus, PANC-1 SP cells may serve as a model for studying drug-resistant pancreatic CSCs, and garcinol has the potential as an antagonist against pancreatic CSCs.

Original languageEnglish
Pages (from-to)165-173
Number of pages9
JournalBiotechnology and Applied Biochemistry
Volume64
Issue number2
DOIs
Publication statusPublished - Mar 1 2017

Fingerprint

Neoplastic Stem Cells
Antioxidants
Side-Population Cells
Pancreatic Neoplasms
Tumors
Down-Regulation
Cells
gemcitabine
Population
Neoplasms
MicroRNAs
garcinol
Up-Regulation
Phenotype
Cell Line
Pharmaceutical Preparations

Keywords

  • Drug resistance
  • Garcinol
  • Notch1
  • Pancreatic cancer stem-like cells
  • Side population cells

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Biomedical Engineering
  • Molecular Medicine
  • Drug Discovery
  • Process Chemistry and Technology

Cite this

@article{43068f6946ea49e49c70ef9c5e123050,
title = "Garcinol downregulates notch1 signaling via modulating mir-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells",
abstract = "Pancreatic cancer represents one of the most aggressive types of malignancy due to its high resistance toward most clinically available treatments. The presence of pancreatic cancer stem-like cells (CSCs) has been attributed to the intrinsically high resistance and highly metastatic potential of this disease. Here, we identified and isolated pancreatic CSCs using the side population (SP) method from human pancreatic cancer cell line, PANC-1. We then compared the SP and non-SP PANC-1 cells genetically. PANC-1 SP cells exhibited CSC properties including enhanced self-renewal ability, increased metastatic potential, and resistance toward gemcitabine treatment. These cancer stem-like phenotypes were supported by their enhanced expression of ABCG2, Oct4, and CD44. A traditional plant-derived antioxidant, garcinol, has been implicated for its anticancer properties. Here, we found that garcinol treatment to PANC-1 SP cells significantly suppressed the stem-like properties of PANC-1 SP cells and metastatic potential by downregulating the expression of Mcl-1, EZH2, ABCG2, Gli-1, and Notch1. More importantly, garcinol treatment led to the upregulation of several tumor suppressor microRNAs, and miR-200c increased by garcinol treatment was found to target and downregulate Notch1. Thus, PANC-1 SP cells may serve as a model for studying drug-resistant pancreatic CSCs, and garcinol has the potential as an antagonist against pancreatic CSCs.",
keywords = "Drug resistance, Garcinol, Notch1, Pancreatic cancer stem-like cells, Side population cells",
author = "Huang, {Chi Cheng} and Lin, {Chien Min} and Huang, {Yan Jiun} and Li Wei and Ting, {Lei Li} and Kuo, {Chia Chun} and Cheyu Hsu and Chiou, {Jeng Fong} and Wu, {Alexander T.H.} and Lee, {Wei Hwa}",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/bab.1446",
language = "English",
volume = "64",
pages = "165--173",
journal = "Biotechnology and Applied Biochemistry",
issn = "0885-4513",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Garcinol downregulates notch1 signaling via modulating mir-200c and suppresses oncogenic properties of PANC-1 cancer stem-like cells

AU - Huang, Chi Cheng

AU - Lin, Chien Min

AU - Huang, Yan Jiun

AU - Wei, Li

AU - Ting, Lei Li

AU - Kuo, Chia Chun

AU - Hsu, Cheyu

AU - Chiou, Jeng Fong

AU - Wu, Alexander T.H.

AU - Lee, Wei Hwa

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Pancreatic cancer represents one of the most aggressive types of malignancy due to its high resistance toward most clinically available treatments. The presence of pancreatic cancer stem-like cells (CSCs) has been attributed to the intrinsically high resistance and highly metastatic potential of this disease. Here, we identified and isolated pancreatic CSCs using the side population (SP) method from human pancreatic cancer cell line, PANC-1. We then compared the SP and non-SP PANC-1 cells genetically. PANC-1 SP cells exhibited CSC properties including enhanced self-renewal ability, increased metastatic potential, and resistance toward gemcitabine treatment. These cancer stem-like phenotypes were supported by their enhanced expression of ABCG2, Oct4, and CD44. A traditional plant-derived antioxidant, garcinol, has been implicated for its anticancer properties. Here, we found that garcinol treatment to PANC-1 SP cells significantly suppressed the stem-like properties of PANC-1 SP cells and metastatic potential by downregulating the expression of Mcl-1, EZH2, ABCG2, Gli-1, and Notch1. More importantly, garcinol treatment led to the upregulation of several tumor suppressor microRNAs, and miR-200c increased by garcinol treatment was found to target and downregulate Notch1. Thus, PANC-1 SP cells may serve as a model for studying drug-resistant pancreatic CSCs, and garcinol has the potential as an antagonist against pancreatic CSCs.

AB - Pancreatic cancer represents one of the most aggressive types of malignancy due to its high resistance toward most clinically available treatments. The presence of pancreatic cancer stem-like cells (CSCs) has been attributed to the intrinsically high resistance and highly metastatic potential of this disease. Here, we identified and isolated pancreatic CSCs using the side population (SP) method from human pancreatic cancer cell line, PANC-1. We then compared the SP and non-SP PANC-1 cells genetically. PANC-1 SP cells exhibited CSC properties including enhanced self-renewal ability, increased metastatic potential, and resistance toward gemcitabine treatment. These cancer stem-like phenotypes were supported by their enhanced expression of ABCG2, Oct4, and CD44. A traditional plant-derived antioxidant, garcinol, has been implicated for its anticancer properties. Here, we found that garcinol treatment to PANC-1 SP cells significantly suppressed the stem-like properties of PANC-1 SP cells and metastatic potential by downregulating the expression of Mcl-1, EZH2, ABCG2, Gli-1, and Notch1. More importantly, garcinol treatment led to the upregulation of several tumor suppressor microRNAs, and miR-200c increased by garcinol treatment was found to target and downregulate Notch1. Thus, PANC-1 SP cells may serve as a model for studying drug-resistant pancreatic CSCs, and garcinol has the potential as an antagonist against pancreatic CSCs.

KW - Drug resistance

KW - Garcinol

KW - Notch1

KW - Pancreatic cancer stem-like cells

KW - Side population cells

UR - http://www.scopus.com/inward/record.url?scp=85011063046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011063046&partnerID=8YFLogxK

U2 - 10.1002/bab.1446

DO - 10.1002/bab.1446

M3 - Article

VL - 64

SP - 165

EP - 173

JO - Biotechnology and Applied Biochemistry

JF - Biotechnology and Applied Biochemistry

SN - 0885-4513

IS - 2

ER -